Integra Lifesciences Holdings Corp (IART)
17.87
+0.40
(+2.29%)
USD |
NASDAQ |
Sep 27, 16:00
17.90
+0.02
(+0.14%)
After-Hours: 20:00
Integra Lifesciences Holdings Accounts Payable (Quarterly): 107.49M for June 30, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 107.49M |
March 31, 2024 | 94.40M |
December 31, 2023 | 92.33M |
September 30, 2023 | 93.55M |
June 30, 2023 | 99.77M |
March 31, 2023 | 112.78M |
December 31, 2022 | 102.10M |
September 30, 2022 | 80.73M |
June 30, 2022 | 69.50M |
March 31, 2022 | 88.37M |
December 31, 2021 | 61.84M |
September 30, 2021 | 59.60M |
June 30, 2021 | 65.51M |
March 31, 2021 | 61.50M |
December 31, 2020 | 54.61M |
September 30, 2020 | 50.25M |
June 30, 2020 | 58.29M |
March 31, 2020 | 97.06M |
December 31, 2019 | 113.09M |
September 30, 2019 | 94.16M |
June 30, 2019 | 107.19M |
March 31, 2019 | 100.55M |
December 31, 2018 | 76.05M |
September 30, 2018 | 86.38M |
June 30, 2018 | 84.04M |
Date | Value |
---|---|
March 31, 2018 | 87.00M |
December 31, 2017 | 93.97M |
September 30, 2017 | 40.74M |
June 30, 2017 | 42.19M |
March 31, 2017 | 45.59M |
December 31, 2016 | 29.06M |
September 30, 2016 | 38.93M |
June 30, 2016 | 43.95M |
March 31, 2016 | 53.99M |
December 31, 2015 | 34.77M |
September 30, 2015 | 38.59M |
June 30, 2015 | 58.20M |
March 31, 2015 | 42.63M |
December 31, 2014 | 28.87M |
September 30, 2014 | 45.94M |
June 30, 2014 | 47.00M |
March 31, 2014 | 46.43M |
December 31, 2013 | 50.75M |
September 30, 2013 | 54.47M |
June 30, 2013 | 44.77M |
March 31, 2013 | 43.88M |
December 31, 2012 | 36.74M |
September 30, 2012 | 43.24M |
June 30, 2012 | 43.19M |
March 31, 2012 | 35.58M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
50.25M
Minimum
Sep 2020
113.09M
Maximum
Dec 2019
82.85M
Average
90.35M
Median
Accounts Payable (Quarterly) Benchmarks
Abbott Laboratories | 4.125B |
Haemonetics Corp | 76.93M |
Globus Medical Inc | 67.16M |
Perspective Therapeutics Inc | 6.127M |
Xtant Medical Holdings Inc | 6.875M |